U3 Pharma

U3 Pharma specializes in the development of targeted cancer drugs within the pharmaceutical industry.

Launch date

2001

Employees

Market cap

Enterprise valuation

Company register number HRB 177122

Planegg Bavaria (HQ & founding location)

Date	Investors	Amount	Round
Jan 2001	Max Planck Institute for Biological Intelligence Max Planck Institute of Biochemistry Max Planck Innovation Max Planck Society	N/A	Spinout
Oct 2003	Atlas Venture Edmond de Rothschild Group	€14.4m	Early VC
May 2006*	Atlas Venture EQT Life Sciences Alta Partners Bio*One Capital Edmond de Rothschild Group	$34.0m	Late VC
May 2008	Daiichi Sankyo	N/A	Acquisition
Total Funding		CAD68.0m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about U3 Pharma